Drug Type Monoclonal antibody |
Synonyms Anti-MIF monoclonal antibody, Immunoglobulin g1-kappa, anti-(homo sapiens mif (macrophage migration inhibitory factor, glycosylation-inhibiting factor, glif, gif)), homo sapiens monoclonal antibody, BAX-069 + [1] |
Target |
Mechanism MIF inhibitors(Macrophage migration inhibitory factor inhibitors), Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ovarian Cancer | Phase 2 | US | 02 Nov 2015 | |
Refractory Ovarian Carcinoma | Phase 2 | US | 02 Nov 2015 | |
Malignant ascites | Phase 2 | US | 02 Nov 2015 | |
Metastatic Colorectal Carcinoma | Phase 2 | US | 15 Jun 2015 | |
Ascites | Phase 2 | - | - | |
Ascites | Phase 2 | - | - | |
Colorectal Cancer | Phase 2 | ES | - | |
Colorectal Cancer | Phase 2 | - | - | |
Lupus Nephritis | Phase 1 | US | 28 Nov 2011 | |
Solid tumor | Phase 1 | US | - |
Phase 1 | 68 | tfeepaolxc(upksyiqibt) = cwawccfrvy ufnkhygige (alslnojqav ) View more | Positive | 01 Sep 2020 | |||
Phase 1/2 | 2 | (Single-Route Arm) | qvwkcnebjn(ucxvbogyoe) = skxmtacqvl hpgmqlvmfp (gfgdnjfcad, ldbugxnhvi - asmgonhbft) View more | - | 15 Jun 2017 | ||
(Double-Route Arm) | qvwkcnebjn(ucxvbogyoe) = doovahowik hpgmqlvmfp (gfgdnjfcad, zdhcfomeus - kyszvjgcex) View more |